Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DIGITAL BRANDS GROUP, INC. (DBGI)

  • Business News
  • April 23, 2026, 12:40 UTC
  • 4
  • 1 comments

DBGI Announces 18-Month Partnership with Social Media Sensation Katie Feeney and Her 14+ Million Followers

Market reaction Comment Full text

Clearbridge Health Limited (1H3)

  • Business News
  • April 23, 2026, 12:39 UTC
  • 4
  • 1 comments

Clearbridge Health Ltd Announcement

Market reaction Comment Full text

Clearbridge Health Limited (1H3)

  • Business News
  • April 23, 2026, 12:35 UTC
  • 4
  • 1 comments

REPL::Annual General Meeting::Voluntary

Market reaction Comment Full text

PAVmed Inc (PAVMZ)

  • Business News
  • April 23, 2026, 12:32 UTC
  • 4
  • 1 comments

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Market reaction Comment Full text

Lucid Diagnostics Inc. (LUCD)

  • Business News
  • April 23, 2026, 12:32 UTC
  • 4
  • 1 comments

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Market reaction Comment Full text

ENERGIX-RENEWABLE ENERGIES LTD (ENRG)

  • Business News
  • April 23, 2026, 12:31 UTC
  • 6
  • 1 comments

Financial Close with Respect to a 152 MWp Project in Ohio

Market reaction Comment Full text

TRUTANKLESS, INC. (GWH)

  • Business News
  • April 23, 2026, 12:31 UTC
  • 6
  • 1 comments

ESS to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time

Market reaction Comment Full text

REBORN COFFEE, INC. (REBN)

  • Business News
  • April 23, 2026, 12:31 UTC
  • 6
  • 1 comments

Reborn Coffee Provides Full Year 2025 Corporate Update and Financial Results

Market reaction Comment Full text

Inogen Inc (INGN)

  • Business News
  • April 23, 2026, 12:30 UTC
  • 4
  • 1 comments

Inogen to Report First Quarter 2026 Financial Results on May 7, 2026

Market reaction Comment Full text

RenovoRx Inc. (RNXT)

  • Business News
  • April 23, 2026, 12:30 UTC
  • 4
  • 1 comments

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

Market reaction Comment Full text
  • Previous
  • 1184
  • 1185
  • 1186
  • 1187
  • 1188
  • Next

Search

News categories

  • Technical Exchange News(12470)
  • Event(6229)
  • SEC News(281113)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161103)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin